Eli Lilly Quietly Works on Wearable Devices in Lab Established in 2015
Eli Lilly continues to make investments in its diabetes business. Source: BioSpace
Pfizer and Genentech Duke it Out in Court over Herceptin Biosimilar Patents
Genentech is claiming that Pfizer's proposed biosimilar infringes 40 of its patents. Source: BioSpace
Massachusetts Upstart Takes on Mighty Purdue Pharma Over Tougher-to-Abuse Opioids
A number of biopharma companies are making strides in developing non-opioid pain killers or opioids that are more difficult to abuse. Source: BioSpace
The Biotech That Has Almost Doubled in 2017 With the Potential to Boom Even More
Keith Speights, writing for The Motley Fool, notes one biotech that's booming. Source: BioSpace
Canada's Concordia Accused of 6,000% Price Increase for Drug, Overcharging NHS by 100M Pounds
The price of a single pill went up from 16p to 9.22 pounds, even though production costs remained broadly stable during that period, the CMA said. Source: BioSpace
GlaxoSmithKline's ViiV Healthcare Wins First FDA OK for Two-Drug HIV Regimen
HIV patients have a new maintenance drug in their arsenal of medication. Source: BioSpace
This is What Amazon Can Do to Start Selling Drugs Faster
Both Amazon and Rite Aid offered no comment for this story. Source: BioSpace
Heptares Founder Shares Her Best Life Sciences Career Advice
Fiona Marshall founded Heptares Therapeutics, which is now one of the leading biotech companies in the UK. Source: BioSpace
Puma Biotechnology and Specialised Therapeutics Asia Enter into Exclusive Licensing Agreement to …
Puma will receive upfront and milestone payments of up to $4.5 million throughout the term of this agreement. Source: BioSpace
FDA Warns Indiana Compounder Over Unapproved Drugs
The FDA cited a compounding pharmacy in Indiana for producing unapproved drugs and for violations of sanitary standards. Source: Drug Industry Daily
- Go to the previous page
- 1
- …
- 248
- 249
- 250
- 251
- 252
- 253
- 254
- …
- 610
- Go to the next page